Clinical Trials Browser

Phase 2 × Thrombocythemia, Essential × Alemtuzumab × Clear all

NCT00069992 2012-10-10

MPDMDSBMT

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis